Miller Howard Investments Inc Pfizer Inc Transaction History

Miller Howard Investments Inc

$3.22 Billion
Q3 2024

A detailed history of Miller Howard Investments Inc transactions in Pfizer Inc stock. As of the latest transaction made, Miller Howard Investments Inc holds 20,497 shares of PFE stock, worth $525,748. This represents 0.02% of its overall portfolio holdings.

Number of Shares

20,497

Previous 18,506 10.76%

Holding current value

$525,748

Previous $517,000 14.7%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$27.7 - $31.39 $55,150 - $62,497	1,991 Added 10.76%	20,497 $593,000
Q2 2024 Jul 26, 2024	BUY	$25.26 - $29.6 $3,056 - $3,581	121 Added 0.66%	18,506 $517,000
Q1 2024 Apr 12, 2024	BUY	$25.89 - $29.73 $29,359 - $33,713	1,134 Added 6.57%	18,385 $510,000
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $13,770 - $17,886	-527 Reduced 2.96%	17,251 $496,000
Q3 2023 Oct 18, 2023	SELL	$32.09 - $37.51 $15,563 - $18,192	-485 Reduced 2.66%	17,778 $589,000
Q2 2023 Jul 21, 2023	SELL	$36.12 - $41.79 $23,550 - $27,247	-652 Reduced 3.45%	18,263 $669,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $28,872 - $37,588	733 Added 4.03%	18,915 $771,000
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $167 - $218	-4 Reduced 0.02%	18,182 $932,000
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $8,533 - $10,416	195 Added 1.08%	18,186 $796,000
Q2 2022 Jul 26, 2022	BUY	$46.53 - $55.17 $169,090 - $200,487	3,634 Added 25.31%	17,991 $943,000
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $4,849 - $6,009	-106 Reduced 0.73%	14,357 $743,000
Q4 2021 Feb 03, 2022	BUY	$41.32 - $61.25 $5,041 - $7,472	122 Added 0.85%	14,463 $854,000
Q3 2021 Oct 21, 2021	SELL	$39.25 - $50.42 $146,245 - $187,864	-3,726 Reduced 20.62%	14,341 $617,000
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $29.3 Million - $33.2 Million	-815,465 Reduced 97.83%	18,067 $708,000
Q1 2021 Apr 16, 2021	SELL	$33.49 - $37.77 $411,056 - $463,588	-12,274 Reduced 1.45%	833,532 $30.2 Million
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $306,585 - $389,849	9,160 Added 1.09%	845,806 $31.1 Million
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $1.61 Million - $1.89 Million	-50,713 Reduced 5.72%	836,646 $30.7 Million
Q2 2020 Jul 29, 2020	SELL	$30.12 - $36.54 $3.9 Million - $4.73 Million	-129,513 Reduced 12.74%	887,359 $29 Million
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $3.42 Million - $4.88 Million	-126,397 Reduced 11.06%	1,016,872 $33.2 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $1.61 Million - $1.83 Million	-49,028 Reduced 4.11%	1,143,269 $44.8 Million
Q3 2019 Oct 17, 2019	SELL	$32.49 - $42.13 $25.9 Million - $33.6 Million	-797,709 Reduced 40.09%	1,192,297 $42.8 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $5.29 Million - $5.94 Million	-143,124 Reduced 6.71%	1,990,006 $86.2 Million
Q1 2019 Apr 22, 2019	SELL	$37.5 - $41.2 $4.02 Million - $4.42 Million	-107,313 Reduced 4.79%	2,133,130 $90.6 Million
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $2.94 Million - $3.35 Million	-76,448 Reduced 3.3%	2,240,443 $97.8 Million
Q3 2018 Oct 29, 2018	SELL	$34.47 - $41.81 $2.36 Million - $2.86 Million	-68,467 Reduced 2.87%	2,316,891 $102 Million
Q2 2018 Jul 17, 2018	SELL	$32.98 - $35.16 $2.25 Million - $2.4 Million	-68,141 Reduced 2.78%	2,385,358 $86.5 Million
Q1 2018 Apr 23, 2018	BUY	$31.91 - $37.02 $9.04 Million - $10.5 Million	283,317 Added 13.05%	2,453,499 $87.1 Million
Q4 2017 Jan 26, 2018	SELL	$33.26 - $35.29 $5.72 Million - $6.07 Million	-171,895 Reduced 7.34%	2,170,182 $78.6 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $72.6 Million - $80 Million	2,342,077	2,342,077 $83.6 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Howard Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Miller Howard Investments Inc with notifications on news.

Account

Miller Howard Investments Inc Pfizer Inc Transaction History